Tanya S. Geist, RPAC

Tanya Geist practices at Dent Neurologic Institute in Amherst, New York.

Tanya Geist's NPI, 1174666945, was assigned on February 14, 2007. Tanya Geist holds New York license 007834.

Tanya Geist's primary practice is Dent Neurologic Institute, at 3980 Sheridan Dr, Amherst, NY 14226-1727. The practice phone is (716) 250-2000.

Tanya Geist's primary practice is Dent Neurologic Institute in Amherst, New York. Tanya Geist is also affiliated with Buffalo General Medical Center/Gates Vascular Institute. The medical group on file is DENT Neurologic Institute. Dmand AI also links Tanya Geist to 2 more hospitals, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Tanya Geist practices, 5 sites in all. Vendor and product names are available with a free account.

Surgical is Tanya Geist's primary specialty in the NPI Registry, under taxonomy code 363AS0400X. Tanya Geist is licensed in New York.

Dmand AI lists acute mini-stroke (TIA), epilepsy, hereditary polyneuropathy, lower back pain, migraine and chronic headache, mobility impairment, multiple sclerosis and muscle disease among the conditions Tanya Geist treats.

CMS data shows 498 Medicare services from Tanya Geist across 5 procedure codes in 2024, for 187 Medicare patients. Medicare paid $25,479 for them. Every service was in an office.

CMS counts 187 Medicare patients who saw Tanya Geist in 2024. The largest group is 65 to 74, with 81 patients. 75% of them have high cholesterol, and 61% have high blood pressure. 28% are also on Medicaid. Their average risk score is 1.50, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Tanya Geist's median patient age at 64, with 65% women.

In 2024, Tanya Geist wrote 3,087 Medicare Part D claims for 462 patients. 90% of them were for generic drugs. CMS names the drug for 2,856 of them, across 62 drugs with 11 or more claims each, at $2,195,316 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 44 out of 100 for Tanya Geist for performance year 2024, reported as part of a group. Tanya Geist accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Tanya Geist as offering telehealth.

CMS Open Payments shows 227 general payments to Tanya Geist from 39 drug and device companies in 2025. Consulting fees make up the largest share, 43% of the total. Amgen Inc. paid the most, $5,262.